IMMNOV — Immunovia AB (publ) Cashflow Statement
0.000.00%
Last trade - 00:00- SEK108.57m
- SEK31.97m
- SEK0.69m
Annual cashflow statement for Immunovia AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -167 | -191 | -296 | -109 | -80.4 |
| Depreciation | |||||
| Non-Cash Items | 0.985 | 23.5 | -1.2 | 19.4 | 0.907 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -6.07 | -7.9 | 8.88 | -6.76 | 1.08 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -153 | -176 | -147 | -96.8 | -78.4 |
| Capital Expenditures | -24.2 | -1.62 | -1.06 | 0 | -5.56 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.358 | 0 | 4.26 | 0 | -0.134 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -23.8 | -1.62 | 3.2 | 0 | -5.69 |
| Financing Cash Flow Items | 0 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -5.27 | -5.11 | 115 | 44.8 | 137 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -181 | -181 | -29.3 | -51.5 | 52.1 |